Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Dexmedetomidine on Sevoflurane MAC-BAR During Pneumoperitoneum
ChiCTR2300071257Phase 4Completed
- Sponsor
- Fujian Provincial Hospital
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in gallbladder disease (3 arms), sponsored by Fujian Provincial Hospital. Primary endpoint: Minimum alveolar concentration to block adrenergic response (MAC-BAR) of sevoflurane. Started May 2024; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
gallbladder disease
Beyond the preview
Go deeper on ChiCTR2300071257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071257.